nodes	percent_of_prediction	percent_of_DWPC	metapath
Levetiracetam—ABCC2—Vincristine—muscle cancer	0.182	0.213	CbGbCtD
Levetiracetam—ABCC2—Etoposide—muscle cancer	0.167	0.195	CbGbCtD
Levetiracetam—ABCC2—Doxorubicin—muscle cancer	0.114	0.133	CbGbCtD
Levetiracetam—ABCC2—Methotrexate—muscle cancer	0.11	0.129	CbGbCtD
Levetiracetam—ABCB1—Dactinomycin—muscle cancer	0.0964	0.113	CbGbCtD
Levetiracetam—ABCB1—Vincristine—muscle cancer	0.0594	0.0693	CbGbCtD
Levetiracetam—ABCB1—Etoposide—muscle cancer	0.0544	0.0635	CbGbCtD
Levetiracetam—ABCB1—Doxorubicin—muscle cancer	0.0371	0.0433	CbGbCtD
Levetiracetam—ABCB1—Methotrexate—muscle cancer	0.0359	0.042	CbGbCtD
Levetiracetam—Infection—Dactinomycin—muscle cancer	0.000542	0.00377	CcSEcCtD
Levetiracetam—Vertigo—Vincristine—muscle cancer	0.000537	0.00374	CcSEcCtD
Levetiracetam—Hepatic failure—Methotrexate—muscle cancer	0.000536	0.00373	CcSEcCtD
Levetiracetam—Leukopenia—Vincristine—muscle cancer	0.000535	0.00372	CcSEcCtD
Levetiracetam—Thrombocytopenia—Dactinomycin—muscle cancer	0.000534	0.00372	CcSEcCtD
Levetiracetam—Erythema multiforme—Etoposide—muscle cancer	0.000526	0.00366	CcSEcCtD
Levetiracetam—Anorexia—Dactinomycin—muscle cancer	0.00052	0.00362	CcSEcCtD
Levetiracetam—Eye disorder—Etoposide—muscle cancer	0.00052	0.00362	CcSEcCtD
Levetiracetam—Ecchymosis—Doxorubicin—muscle cancer	0.000519	0.00361	CcSEcCtD
Levetiracetam—Mouth ulceration—Doxorubicin—muscle cancer	0.000519	0.00361	CcSEcCtD
Levetiracetam—Convulsion—Vincristine—muscle cancer	0.000518	0.0036	CcSEcCtD
Levetiracetam—Myalgia—Vincristine—muscle cancer	0.000509	0.00354	CcSEcCtD
Levetiracetam—Immune system disorder—Etoposide—muscle cancer	0.000502	0.0035	CcSEcCtD
Levetiracetam—Mediastinal disorder—Etoposide—muscle cancer	0.000501	0.00349	CcSEcCtD
Levetiracetam—Mental disability—Doxorubicin—muscle cancer	0.000498	0.00347	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000497	0.00346	CcSEcCtD
Levetiracetam—Alopecia—Etoposide—muscle cancer	0.000491	0.00342	CcSEcCtD
Levetiracetam—Lethargy—Methotrexate—muscle cancer	0.000491	0.00342	CcSEcCtD
Levetiracetam—Infection—Vincristine—muscle cancer	0.000485	0.00337	CcSEcCtD
Levetiracetam—Nervous system disorder—Vincristine—muscle cancer	0.000478	0.00333	CcSEcCtD
Levetiracetam—Thrombocytopenia—Vincristine—muscle cancer	0.000478	0.00332	CcSEcCtD
Levetiracetam—Decreased appetite—Dactinomycin—muscle cancer	0.000475	0.0033	CcSEcCtD
Levetiracetam—Fatigue—Dactinomycin—muscle cancer	0.000471	0.00328	CcSEcCtD
Levetiracetam—Back pain—Etoposide—muscle cancer	0.000468	0.00326	CcSEcCtD
Levetiracetam—Pain—Dactinomycin—muscle cancer	0.000467	0.00325	CcSEcCtD
Levetiracetam—Anorexia—Vincristine—muscle cancer	0.000465	0.00324	CcSEcCtD
Levetiracetam—Eczema—Doxorubicin—muscle cancer	0.000464	0.00323	CcSEcCtD
Levetiracetam—Hepatic failure—Doxorubicin—muscle cancer	0.000464	0.00323	CcSEcCtD
Levetiracetam—Irritability—Methotrexate—muscle cancer	0.00046	0.0032	CcSEcCtD
Levetiracetam—Mood swings—Methotrexate—muscle cancer	0.000456	0.00317	CcSEcCtD
Levetiracetam—Ataxia—Methotrexate—muscle cancer	0.000453	0.00315	CcSEcCtD
Levetiracetam—Feeling abnormal—Dactinomycin—muscle cancer	0.00045	0.00313	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000446	0.00311	CcSEcCtD
Levetiracetam—Liver function test abnormal—Methotrexate—muscle cancer	0.000445	0.00309	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000444	0.00309	CcSEcCtD
Levetiracetam—Insomnia—Vincristine—muscle cancer	0.000441	0.00307	CcSEcCtD
Levetiracetam—Renal impairment—Doxorubicin—muscle cancer	0.000438	0.00305	CcSEcCtD
Levetiracetam—Paraesthesia—Vincristine—muscle cancer	0.000438	0.00305	CcSEcCtD
Levetiracetam—Dermatitis bullous—Doxorubicin—muscle cancer	0.000436	0.00304	CcSEcCtD
Levetiracetam—Vertigo—Etoposide—muscle cancer	0.000435	0.00303	CcSEcCtD
Levetiracetam—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.000434	0.00302	CcSEcCtD
Levetiracetam—Leukopenia—Etoposide—muscle cancer	0.000433	0.00302	CcSEcCtD
Levetiracetam—Abdominal pain—Dactinomycin—muscle cancer	0.000432	0.003	CcSEcCtD
Levetiracetam—Body temperature increased—Dactinomycin—muscle cancer	0.000432	0.003	CcSEcCtD
Levetiracetam—Lethargy—Doxorubicin—muscle cancer	0.000425	0.00296	CcSEcCtD
Levetiracetam—Decreased appetite—Vincristine—muscle cancer	0.000424	0.00295	CcSEcCtD
Levetiracetam—Cough—Etoposide—muscle cancer	0.000422	0.00294	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Vincristine—muscle cancer	0.000421	0.00293	CcSEcCtD
Levetiracetam—Fatigue—Vincristine—muscle cancer	0.00042	0.00293	CcSEcCtD
Levetiracetam—Convulsion—Etoposide—muscle cancer	0.000419	0.00292	CcSEcCtD
Levetiracetam—Hyponatraemia—Doxorubicin—muscle cancer	0.000419	0.00291	CcSEcCtD
Levetiracetam—Constipation—Vincristine—muscle cancer	0.000417	0.0029	CcSEcCtD
Levetiracetam—Pain—Vincristine—muscle cancer	0.000417	0.0029	CcSEcCtD
Levetiracetam—Diplopia—Doxorubicin—muscle cancer	0.000417	0.0029	CcSEcCtD
Levetiracetam—Asthma—Methotrexate—muscle cancer	0.000416	0.0029	CcSEcCtD
Levetiracetam—Chest pain—Etoposide—muscle cancer	0.000412	0.00287	CcSEcCtD
Levetiracetam—Eosinophilia—Methotrexate—muscle cancer	0.000412	0.00287	CcSEcCtD
Levetiracetam—Affect lability—Doxorubicin—muscle cancer	0.00041	0.00286	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000409	0.00285	CcSEcCtD
Levetiracetam—Pancreatitis—Methotrexate—muscle cancer	0.000408	0.00284	CcSEcCtD
Levetiracetam—Face oedema—Doxorubicin—muscle cancer	0.000403	0.0028	CcSEcCtD
Levetiracetam—Hypersensitivity—Dactinomycin—muscle cancer	0.000402	0.0028	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Vincristine—muscle cancer	0.000399	0.00278	CcSEcCtD
Levetiracetam—Confusional state—Etoposide—muscle cancer	0.000398	0.00277	CcSEcCtD
Levetiracetam—Pancytopenia—Methotrexate—muscle cancer	0.000395	0.00275	CcSEcCtD
Levetiracetam—Mood swings—Doxorubicin—muscle cancer	0.000395	0.00275	CcSEcCtD
Levetiracetam—Infection—Etoposide—muscle cancer	0.000393	0.00273	CcSEcCtD
Levetiracetam—Ataxia—Doxorubicin—muscle cancer	0.000392	0.00273	CcSEcCtD
Levetiracetam—Asthenia—Dactinomycin—muscle cancer	0.000392	0.00273	CcSEcCtD
Levetiracetam—Neutropenia—Methotrexate—muscle cancer	0.000389	0.00271	CcSEcCtD
Levetiracetam—Dehydration—Doxorubicin—muscle cancer	0.000388	0.0027	CcSEcCtD
Levetiracetam—Thrombocytopenia—Etoposide—muscle cancer	0.000387	0.00269	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000387	0.00269	CcSEcCtD
Levetiracetam—Abdominal pain—Vincristine—muscle cancer	0.000386	0.00268	CcSEcCtD
Levetiracetam—Body temperature increased—Vincristine—muscle cancer	0.000386	0.00268	CcSEcCtD
Levetiracetam—Liver function test abnormal—Doxorubicin—muscle cancer	0.000385	0.00268	CcSEcCtD
Levetiracetam—Skin disorder—Etoposide—muscle cancer	0.000384	0.00267	CcSEcCtD
Levetiracetam—Abdominal pain upper—Doxorubicin—muscle cancer	0.000381	0.00265	CcSEcCtD
Levetiracetam—Anorexia—Etoposide—muscle cancer	0.000377	0.00262	CcSEcCtD
Levetiracetam—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000375	0.00261	CcSEcCtD
Levetiracetam—Diarrhoea—Dactinomycin—muscle cancer	0.000373	0.0026	CcSEcCtD
Levetiracetam—Nasopharyngitis—Doxorubicin—muscle cancer	0.000373	0.00259	CcSEcCtD
Levetiracetam—Infestation—Methotrexate—muscle cancer	0.000371	0.00258	CcSEcCtD
Levetiracetam—Drowsiness—Methotrexate—muscle cancer	0.000371	0.00258	CcSEcCtD
Levetiracetam—Infestation NOS—Methotrexate—muscle cancer	0.000371	0.00258	CcSEcCtD
Levetiracetam—Depression—Methotrexate—muscle cancer	0.00037	0.00257	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000368	0.00256	CcSEcCtD
Levetiracetam—Muscular weakness—Doxorubicin—muscle cancer	0.000368	0.00256	CcSEcCtD
Levetiracetam—Stomatitis—Methotrexate—muscle cancer	0.000362	0.00252	CcSEcCtD
Levetiracetam—Conjunctivitis—Methotrexate—muscle cancer	0.000361	0.00251	CcSEcCtD
Levetiracetam—Asthma—Doxorubicin—muscle cancer	0.00036	0.00251	CcSEcCtD
Levetiracetam—Influenza—Doxorubicin—muscle cancer	0.00036	0.00251	CcSEcCtD
Levetiracetam—Hypersensitivity—Vincristine—muscle cancer	0.000359	0.0025	CcSEcCtD
Levetiracetam—Eosinophilia—Doxorubicin—muscle cancer	0.000357	0.00248	CcSEcCtD
Levetiracetam—Paraesthesia—Etoposide—muscle cancer	0.000355	0.00247	CcSEcCtD
Levetiracetam—Pancreatitis—Doxorubicin—muscle cancer	0.000353	0.00246	CcSEcCtD
Levetiracetam—Somnolence—Etoposide—muscle cancer	0.000351	0.00244	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Methotrexate—muscle cancer	0.000351	0.00244	CcSEcCtD
Levetiracetam—Epistaxis—Methotrexate—muscle cancer	0.00035	0.00244	CcSEcCtD
Levetiracetam—Asthenia—Vincristine—muscle cancer	0.00035	0.00244	CcSEcCtD
Levetiracetam—Vomiting—Dactinomycin—muscle cancer	0.000347	0.00242	CcSEcCtD
Levetiracetam—Bronchitis—Doxorubicin—muscle cancer	0.000347	0.00241	CcSEcCtD
Levetiracetam—Agranulocytosis—Methotrexate—muscle cancer	0.000346	0.00241	CcSEcCtD
Levetiracetam—Rash—Dactinomycin—muscle cancer	0.000344	0.0024	CcSEcCtD
Levetiracetam—Decreased appetite—Etoposide—muscle cancer	0.000343	0.00239	CcSEcCtD
Levetiracetam—Pancytopenia—Doxorubicin—muscle cancer	0.000342	0.00238	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Etoposide—muscle cancer	0.000341	0.00237	CcSEcCtD
Levetiracetam—Fatigue—Etoposide—muscle cancer	0.000341	0.00237	CcSEcCtD
Levetiracetam—Pain—Etoposide—muscle cancer	0.000338	0.00235	CcSEcCtD
Levetiracetam—Constipation—Etoposide—muscle cancer	0.000338	0.00235	CcSEcCtD
Levetiracetam—Neutropenia—Doxorubicin—muscle cancer	0.000337	0.00234	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000335	0.00233	CcSEcCtD
Levetiracetam—Diarrhoea—Vincristine—muscle cancer	0.000334	0.00232	CcSEcCtD
Levetiracetam—Hepatitis—Methotrexate—muscle cancer	0.000333	0.00232	CcSEcCtD
Levetiracetam—Pharyngitis—Methotrexate—muscle cancer	0.000331	0.0023	CcSEcCtD
Levetiracetam—Weight increased—Doxorubicin—muscle cancer	0.000328	0.00228	CcSEcCtD
Levetiracetam—Weight decreased—Doxorubicin—muscle cancer	0.000326	0.00227	CcSEcCtD
Levetiracetam—Feeling abnormal—Etoposide—muscle cancer	0.000326	0.00227	CcSEcCtD
Levetiracetam—Nausea—Dactinomycin—muscle cancer	0.000324	0.00226	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Etoposide—muscle cancer	0.000323	0.00225	CcSEcCtD
Levetiracetam—Dizziness—Vincristine—muscle cancer	0.000323	0.00224	CcSEcCtD
Levetiracetam—Infestation NOS—Doxorubicin—muscle cancer	0.000321	0.00224	CcSEcCtD
Levetiracetam—Infestation—Doxorubicin—muscle cancer	0.000321	0.00224	CcSEcCtD
Levetiracetam—Drowsiness—Doxorubicin—muscle cancer	0.000321	0.00224	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000319	0.00222	CcSEcCtD
Levetiracetam—Erythema multiforme—Methotrexate—muscle cancer	0.000315	0.00219	CcSEcCtD
Levetiracetam—Stomatitis—Doxorubicin—muscle cancer	0.000313	0.00218	CcSEcCtD
Levetiracetam—Abdominal pain—Etoposide—muscle cancer	0.000312	0.00217	CcSEcCtD
Levetiracetam—Body temperature increased—Etoposide—muscle cancer	0.000312	0.00217	CcSEcCtD
Levetiracetam—Conjunctivitis—Doxorubicin—muscle cancer	0.000312	0.00217	CcSEcCtD
Levetiracetam—Urinary tract infection—Doxorubicin—muscle cancer	0.000312	0.00217	CcSEcCtD
Levetiracetam—Eye disorder—Methotrexate—muscle cancer	0.000311	0.00217	CcSEcCtD
Levetiracetam—Vomiting—Vincristine—muscle cancer	0.00031	0.00216	CcSEcCtD
Levetiracetam—Rash—Vincristine—muscle cancer	0.000308	0.00214	CcSEcCtD
Levetiracetam—Dermatitis—Vincristine—muscle cancer	0.000307	0.00214	CcSEcCtD
Levetiracetam—Headache—Vincristine—muscle cancer	0.000306	0.00213	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000304	0.00211	CcSEcCtD
Levetiracetam—Epistaxis—Doxorubicin—muscle cancer	0.000303	0.00211	CcSEcCtD
Levetiracetam—Sinusitis—Doxorubicin—muscle cancer	0.000301	0.0021	CcSEcCtD
Levetiracetam—Immune system disorder—Methotrexate—muscle cancer	0.000301	0.00209	CcSEcCtD
Levetiracetam—Mediastinal disorder—Methotrexate—muscle cancer	0.0003	0.00209	CcSEcCtD
Levetiracetam—Agranulocytosis—Doxorubicin—muscle cancer	0.0003	0.00209	CcSEcCtD
Levetiracetam—Alopecia—Methotrexate—muscle cancer	0.000294	0.00205	CcSEcCtD
Levetiracetam—Mental disorder—Methotrexate—muscle cancer	0.000292	0.00203	CcSEcCtD
Levetiracetam—Hypersensitivity—Etoposide—muscle cancer	0.000291	0.00203	CcSEcCtD
Levetiracetam—Malnutrition—Methotrexate—muscle cancer	0.00029	0.00202	CcSEcCtD
Levetiracetam—Nausea—Vincristine—muscle cancer	0.00029	0.00202	CcSEcCtD
Levetiracetam—Rhinitis—Doxorubicin—muscle cancer	0.000289	0.00201	CcSEcCtD
Levetiracetam—Hepatitis—Doxorubicin—muscle cancer	0.000288	0.00201	CcSEcCtD
Levetiracetam—Pharyngitis—Doxorubicin—muscle cancer	0.000286	0.00199	CcSEcCtD
Levetiracetam—Asthenia—Etoposide—muscle cancer	0.000283	0.00197	CcSEcCtD
Levetiracetam—Connective tissue disorder—Doxorubicin—muscle cancer	0.000283	0.00197	CcSEcCtD
Levetiracetam—Back pain—Methotrexate—muscle cancer	0.00028	0.00195	CcSEcCtD
Levetiracetam—Pruritus—Etoposide—muscle cancer	0.00028	0.00195	CcSEcCtD
Levetiracetam—Vision blurred—Methotrexate—muscle cancer	0.000273	0.0019	CcSEcCtD
Levetiracetam—Erythema multiforme—Doxorubicin—muscle cancer	0.000273	0.0019	CcSEcCtD
Levetiracetam—Diarrhoea—Etoposide—muscle cancer	0.00027	0.00188	CcSEcCtD
Levetiracetam—Eye disorder—Doxorubicin—muscle cancer	0.00027	0.00188	CcSEcCtD
Levetiracetam—Dizziness—Etoposide—muscle cancer	0.000261	0.00182	CcSEcCtD
Levetiracetam—Immune system disorder—Doxorubicin—muscle cancer	0.000261	0.00181	CcSEcCtD
Levetiracetam—Vertigo—Methotrexate—muscle cancer	0.000261	0.00181	CcSEcCtD
Levetiracetam—Mediastinal disorder—Doxorubicin—muscle cancer	0.00026	0.00181	CcSEcCtD
Levetiracetam—Leukopenia—Methotrexate—muscle cancer	0.00026	0.00181	CcSEcCtD
Levetiracetam—Alopecia—Doxorubicin—muscle cancer	0.000255	0.00177	CcSEcCtD
Levetiracetam—Cough—Methotrexate—muscle cancer	0.000253	0.00176	CcSEcCtD
Levetiracetam—Mental disorder—Doxorubicin—muscle cancer	0.000253	0.00176	CcSEcCtD
Levetiracetam—Convulsion—Methotrexate—muscle cancer	0.000251	0.00175	CcSEcCtD
Levetiracetam—Vomiting—Etoposide—muscle cancer	0.000251	0.00175	CcSEcCtD
Levetiracetam—Malnutrition—Doxorubicin—muscle cancer	0.000251	0.00175	CcSEcCtD
Levetiracetam—Rash—Etoposide—muscle cancer	0.000249	0.00173	CcSEcCtD
Levetiracetam—Dermatitis—Etoposide—muscle cancer	0.000249	0.00173	CcSEcCtD
Levetiracetam—Headache—Etoposide—muscle cancer	0.000248	0.00172	CcSEcCtD
Levetiracetam—Arthralgia—Methotrexate—muscle cancer	0.000247	0.00172	CcSEcCtD
Levetiracetam—Chest pain—Methotrexate—muscle cancer	0.000247	0.00172	CcSEcCtD
Levetiracetam—Myalgia—Methotrexate—muscle cancer	0.000247	0.00172	CcSEcCtD
Levetiracetam—Tension—Doxorubicin—muscle cancer	0.000246	0.00171	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000245	0.00171	CcSEcCtD
Levetiracetam—Nervousness—Doxorubicin—muscle cancer	0.000244	0.0017	CcSEcCtD
Levetiracetam—Back pain—Doxorubicin—muscle cancer	0.000243	0.00169	CcSEcCtD
Levetiracetam—Confusional state—Methotrexate—muscle cancer	0.000239	0.00166	CcSEcCtD
Levetiracetam—Vision blurred—Doxorubicin—muscle cancer	0.000237	0.00165	CcSEcCtD
Levetiracetam—Infection—Methotrexate—muscle cancer	0.000235	0.00164	CcSEcCtD
Levetiracetam—Nausea—Etoposide—muscle cancer	0.000235	0.00163	CcSEcCtD
Levetiracetam—Nervous system disorder—Methotrexate—muscle cancer	0.000232	0.00161	CcSEcCtD
Levetiracetam—Thrombocytopenia—Methotrexate—muscle cancer	0.000232	0.00161	CcSEcCtD
Levetiracetam—Agitation—Doxorubicin—muscle cancer	0.000231	0.00161	CcSEcCtD
Levetiracetam—Skin disorder—Methotrexate—muscle cancer	0.00023	0.0016	CcSEcCtD
Levetiracetam—Vertigo—Doxorubicin—muscle cancer	0.000226	0.00157	CcSEcCtD
Levetiracetam—Anorexia—Methotrexate—muscle cancer	0.000226	0.00157	CcSEcCtD
Levetiracetam—Leukopenia—Doxorubicin—muscle cancer	0.000225	0.00156	CcSEcCtD
Levetiracetam—Cough—Doxorubicin—muscle cancer	0.000219	0.00152	CcSEcCtD
Levetiracetam—Convulsion—Doxorubicin—muscle cancer	0.000218	0.00151	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000216	0.0015	CcSEcCtD
Levetiracetam—Insomnia—Methotrexate—muscle cancer	0.000214	0.00149	CcSEcCtD
Levetiracetam—Myalgia—Doxorubicin—muscle cancer	0.000214	0.00149	CcSEcCtD
Levetiracetam—Chest pain—Doxorubicin—muscle cancer	0.000214	0.00149	CcSEcCtD
Levetiracetam—Arthralgia—Doxorubicin—muscle cancer	0.000214	0.00149	CcSEcCtD
Levetiracetam—Anxiety—Doxorubicin—muscle cancer	0.000213	0.00148	CcSEcCtD
Levetiracetam—Paraesthesia—Methotrexate—muscle cancer	0.000212	0.00148	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000212	0.00148	CcSEcCtD
Levetiracetam—Somnolence—Methotrexate—muscle cancer	0.00021	0.00146	CcSEcCtD
Levetiracetam—Dyspepsia—Methotrexate—muscle cancer	0.000208	0.00145	CcSEcCtD
Levetiracetam—Confusional state—Doxorubicin—muscle cancer	0.000207	0.00144	CcSEcCtD
Levetiracetam—Decreased appetite—Methotrexate—muscle cancer	0.000206	0.00143	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000204	0.00142	CcSEcCtD
Levetiracetam—Fatigue—Methotrexate—muscle cancer	0.000204	0.00142	CcSEcCtD
Levetiracetam—Infection—Doxorubicin—muscle cancer	0.000204	0.00142	CcSEcCtD
Levetiracetam—Pain—Methotrexate—muscle cancer	0.000202	0.00141	CcSEcCtD
Levetiracetam—Nervous system disorder—Doxorubicin—muscle cancer	0.000201	0.0014	CcSEcCtD
Levetiracetam—Thrombocytopenia—Doxorubicin—muscle cancer	0.000201	0.0014	CcSEcCtD
Levetiracetam—Skin disorder—Doxorubicin—muscle cancer	0.000199	0.00139	CcSEcCtD
Levetiracetam—Anorexia—Doxorubicin—muscle cancer	0.000195	0.00136	CcSEcCtD
Levetiracetam—Feeling abnormal—Methotrexate—muscle cancer	0.000195	0.00136	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Methotrexate—muscle cancer	0.000194	0.00135	CcSEcCtD
Levetiracetam—Body temperature increased—Methotrexate—muscle cancer	0.000187	0.0013	CcSEcCtD
Levetiracetam—Abdominal pain—Methotrexate—muscle cancer	0.000187	0.0013	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000187	0.0013	CcSEcCtD
Levetiracetam—Insomnia—Doxorubicin—muscle cancer	0.000185	0.00129	CcSEcCtD
Levetiracetam—Paraesthesia—Doxorubicin—muscle cancer	0.000184	0.00128	CcSEcCtD
Levetiracetam—Somnolence—Doxorubicin—muscle cancer	0.000182	0.00127	CcSEcCtD
Levetiracetam—Dyspepsia—Doxorubicin—muscle cancer	0.00018	0.00126	CcSEcCtD
Levetiracetam—Decreased appetite—Doxorubicin—muscle cancer	0.000178	0.00124	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000177	0.00123	CcSEcCtD
Levetiracetam—Fatigue—Doxorubicin—muscle cancer	0.000177	0.00123	CcSEcCtD
Levetiracetam—Pain—Doxorubicin—muscle cancer	0.000175	0.00122	CcSEcCtD
Levetiracetam—Constipation—Doxorubicin—muscle cancer	0.000175	0.00122	CcSEcCtD
Levetiracetam—Hypersensitivity—Methotrexate—muscle cancer	0.000174	0.00121	CcSEcCtD
Levetiracetam—Asthenia—Methotrexate—muscle cancer	0.00017	0.00118	CcSEcCtD
Levetiracetam—Feeling abnormal—Doxorubicin—muscle cancer	0.000169	0.00118	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000168	0.00117	CcSEcCtD
Levetiracetam—Pruritus—Methotrexate—muscle cancer	0.000167	0.00117	CcSEcCtD
Levetiracetam—Abdominal pain—Doxorubicin—muscle cancer	0.000162	0.00113	CcSEcCtD
Levetiracetam—Body temperature increased—Doxorubicin—muscle cancer	0.000162	0.00113	CcSEcCtD
Levetiracetam—Diarrhoea—Methotrexate—muscle cancer	0.000162	0.00113	CcSEcCtD
Levetiracetam—Dizziness—Methotrexate—muscle cancer	0.000156	0.00109	CcSEcCtD
Levetiracetam—Hypersensitivity—Doxorubicin—muscle cancer	0.000151	0.00105	CcSEcCtD
Levetiracetam—Vomiting—Methotrexate—muscle cancer	0.00015	0.00105	CcSEcCtD
Levetiracetam—Rash—Methotrexate—muscle cancer	0.000149	0.00104	CcSEcCtD
Levetiracetam—Dermatitis—Methotrexate—muscle cancer	0.000149	0.00104	CcSEcCtD
Levetiracetam—Headache—Methotrexate—muscle cancer	0.000148	0.00103	CcSEcCtD
Levetiracetam—Asthenia—Doxorubicin—muscle cancer	0.000147	0.00102	CcSEcCtD
Levetiracetam—Pruritus—Doxorubicin—muscle cancer	0.000145	0.00101	CcSEcCtD
Levetiracetam—Nausea—Methotrexate—muscle cancer	0.000141	0.000978	CcSEcCtD
Levetiracetam—Diarrhoea—Doxorubicin—muscle cancer	0.00014	0.000976	CcSEcCtD
Levetiracetam—Dizziness—Doxorubicin—muscle cancer	0.000136	0.000943	CcSEcCtD
Levetiracetam—Vomiting—Doxorubicin—muscle cancer	0.00013	0.000907	CcSEcCtD
Levetiracetam—Rash—Doxorubicin—muscle cancer	0.000129	0.000899	CcSEcCtD
Levetiracetam—Dermatitis—Doxorubicin—muscle cancer	0.000129	0.000898	CcSEcCtD
Levetiracetam—Headache—Doxorubicin—muscle cancer	0.000128	0.000893	CcSEcCtD
Levetiracetam—Nausea—Doxorubicin—muscle cancer	0.000122	0.000847	CcSEcCtD
